Tesla’s technicals, biotech’s bounce and trading stocks at 52-week highs. 11/22/22
Tesla’s stock has been cut in half this year, trading way below the average Wall Street price target. A technician tells us where she thinks the stock goes next. Plus, money has been rotating into biotech stocks. Is the sector recession proof? And the trade on IBM as the stock hits a 52-week high.
November 22, 202243m 50s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Tesla’s stock has been cut in half this year, trading way below the average Wall Street price target. A technician tells us where she thinks the stock goes next.
Plus, money has been rotating into biotech stocks. Is the sector recession proof?
And the trade on IBM as the stock hits a 52-week high. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.